Expression profiling of supraglottic carcinoma: PTEN and thrombospondin 2 are associated with inhibition of lymphatic metastasis

Acta Oto-Laryngologica

Volumn 129, Issue 5, 2009, Pages 569-574

  Bai, Weiliang ^a   Wang, Liping ^a   Ji, Wenyue ^a   Gao, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CDNA microarray; Laryngeal neoplasms; Lymphatic metastasis

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; THROMBOSPONDIN 2; TRANSCRIPTION FACTOR PEA3; PTEN PROTEIN, HUMAN; THROMBOSPONDIN;

ARTICLE; C ETS2 GENE; CONTROLLED STUDY; DNA MICROARRAY; ETS1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LARYNX TUMOR; MALE; METABOLISM; METASTASIS; SQUAMOUS CELL CARCINOMA; VALIDATION STUDY;

CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PTEN PHOSPHOHYDROLASE; THROMBOSPONDINS;

EID: 67650004067     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480802294351     Document Type: Article

References (21)

1. Akervall J. Genomic screening of head and neck cancer and its implications for therapy planning. Eur Arch Otorhinolaryngol 2006;/263:/297-304.
2. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003;/361:/923-9.
3. Mori M, Shimada H, Gunji Y, Matsubara H, Hayashi H, Nimura Y, et al. S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer. Oncol Rep 2004;/11:/1287-93.
4. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/ pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;/130:/295-302.
5. Nomura T, Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005;/52:/1-9.
6. Erdem NF, Carlson ER, Gerard DA, Ichiki AT. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. J Oral Maxillofac Surg 2007;/65:/1725-33.
7. Bradley WH, Lima PH, Rodgers L, Blomquist CH, Downs LS. Endometrial carcinoma expresses an increased cathepsin B/D ratio. Gynecol Oncol 2008;/108:/84-9.
8. Parker B, Ciocca D, Bidwell B, Gago FE, Fanelli MA, George J, et al. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. J Pathol 2008;/214:/337-46.
9. Endo K, Shirai A, Furukawa M, Yoshizaki T. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Hum Pathol 2006;/37:/ 1111-1116
10. Qiao J, Kang JH, Cree J, Evers BM, Chung DH. Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells. Neoplasia 2007;/9:/184-91.
11. Tsutsumi S, Kuwano H, Nagashima N, Shimura T, Mochiki E, Asao T. Ets-1 expression in gastric cancer. Hepatogastroenterology 2005;/52:/654-6.
12. Cowden Dahl KD, Zeineldin R, Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptorstimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Mol Cancer Res 2007;/5:/413-21.
13. Bai WL, Ren Z, Pan ZM, Gao H. [Expression of KAI1 gene in human laryngeal carcinoma and its clinical significance.] Zhonghua Zhong Liu Za Zhi 2005;27:289-291 (in Chinese).
14. Yang JM, Peng ZH, Si SH, Liu WW, Luo YH, Ye ZY. KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models. Liver Int 2008;/28:/132-9.
15. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Nomoto K, et al. Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma. J Clin Pathol 2007;/ 60:/50-6.
16. Zhang XA, He B, Zhou B, Liu L. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/ CD82-mediated inhibition of cell migration. J Biol Chem 2003;/278:/27319-28.
17. Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci 2008;/121:/249-53.
18. Zhu L, Loo WT, Louis WC. PTEN and VEGF: possible predictors for sentinel lymph node micro-metastasis in breast cancer. Biomed Pharmacother 2007;/61:/558-61.
19. Mi D, Yi J, Liu E, Li X. Relationship between PTEN and VEGF expression and clinicopathological characteristics in HCC. J Huazhong Univ Sci Technolog Med Sci 2006;/26:/ 682-685
20. Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, more than the AKT pathway. Carcinogenesis 2007;/28:/ 1379-1386
21. Detmar M. Tumor angiogenesis. J Investig Dermatol Symp Proc 2000;/5:/20-3.